Lifesprout Company

LifeSprout is developing the next generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. LifeSprout offers revolutionary products for aesthetic and regenerative medicine. Leveraging recent breakthroughs in materials science, we have created a platform that looks and behaves like the body’s own tissues. The company is turning this into a suite of products for millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease.

Founded Date: 2015-01-01
Headquarters: Baltimore, Maryland, United States
Technology: Regenerative Medicine
Employee Number: 1-10
Industry: Biotechnology, Emergency Medicine, Health Care, Medical
Estimated Revenue: $1M to $10M
Funding Status: Early Stage Venture
Investor Type: For Profit